DaVita

Discussion in 'Keryx Biopharmaceuticals' started by anonymous, Dec 6, 2017 at 8:13 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    $4.9 billion cash in pocket to now focus entirely on kidney care business. Okay.
     

  2. anonymous

    anonymous Guest

    DaVita could offer $12/share and the stock would probably sell off into the 3s...
     
  3. anonymous

    anonymous Guest

    lazy-ass board members better be putting out feelers. you can only assume they’ve already turned on ther our-of-office notifications until 2018.
     
  4. anonymous

    anonymous Guest

    Davita’s stock has moved up swiftly the past few weeks (shocker). Makes you speculate that they could try to be opportunistic. Less faith with these execs getting any sort of deal done, ever.
     
  5. anonymous

    anonymous Guest

    $13.50
     
  6. anonymous

    anonymous Guest

    maybe?
     
  7. anonymous

    anonymous Guest

    Guess not.